Therefore, CBP inhibitor SGC-CBP30 can alleviate inflammatory injury in lung and spleen tissues during sepsis by reducing the pro-inflammatory cytokine production and polarization of M1 macrophages. The gene discussed is CREBBP; the disease is Sepsis.